Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy

NCT02422485 is registered in ClinicalTrials.gov with Adam Boxer as lead sponsor.

NCT NCT02422485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02422485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy
Lead sponsor
Adam Boxer
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2015
Completion date
December 31, 2019
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

progressive supranuclear palsy